Tumor safety of biologic agents and targeted therapies in immune-mediated inflammatory arthritides - Quiz - MDSpire

Safety of Biologic and Targeted Therapies in Relation to Tumor Risk in Immune-Mediated Inflammatory Arthritis

  • By

  • Sheng-Guang Li

  • Yadan Zou

  • Ji Li

  • Lina Zhang

  • Jing Zhang

  • Ting Long

  • Ruohan Yu

  • Yanfeng Zhang

  • June 4, 2026

Share

Original Source(s)

Tumor safety of biologic agents and targeted therapies in immune-mediated inflammatory arthritides

  • by Sheng-Guang Li, Yadan Zou, Ji Li, Lina Zhang, Jing Zhang, Ting Long, Ruohan Yu, Yanfeng Zhang

  • June 4, 2026

Related Content

Editorial: Characterising the functional heterogeneity of synovial macrophages

Mechanisms of Epstein-Barr virus-associated autoimmunity: a comparative overview

Tripterygium wilfordii Hook. f. and Xinfeng Capsule in Rheumatoid Arthritis: A Review of Clinical Evidence, Molecular Mechanisms, and Translational Perspectives